Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ·Healthcare·Biotechnology
$5.89
-1.83%
Mkt Cap $53.91M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+188.6%
Consensus $17.00 vs current $5.89
NASDAQ·Healthcare·Biotechnology
$5.89
-1.83%
Mkt Cap $53.91M
No recent rating data.
Price Target (4 analysts)
$17.00
Range $17.00 – $17.00
+188.6%
Consensus $17.00 vs current $5.89